^
    CANCER:

    Oligodendroglioma





    Show legend
    Group by Gene:
    0
    TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
    larotrectinib
    1
    DNA synthesis inhibitor
    cisplatin
    temozolomide
    2
    MEK inhibitor, BRAF inhibitor
    trametinib + dabrafenib
    3
    VEGF-A inhibitor
    bevacizumab
    4
    Alkylating agent
    lomustine
    5
    Tubulin polymerization promoter
    carboplatin
    6
    Topoisomerase II inhibitor
    etoposide IV
    7
    TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
    entrectinib
    8
    Chemotherapy
    PCV
    9
    Alkylating agent, DNA synthesis inhibitor
    carmustine
    10
    BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
    vemurafenib + cobimetinib
    11
    IDH2 inhibitor, IDH1 inhibitor
    S95032
    IDH2 mutation + Chr del(1p) + Chr del(19q)
    IDH2 mutation
    IDH1 mutation + Chr del(1p) + Chr del(19q)
    IDH1 mutation
    IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion
    IDH2 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E
    IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion
    IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion
    IDH1 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E
    IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion
    IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion
    IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion